R. Amaro

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
R. Amaro, Rosanel Amaro
Publication record
70 papers · 547 citations · H-index 14

PAPERS

Frequent exacerbators and Neutrophil Elastase activity in Bronchiectasis: a network analysis approach
20250 citationsauthor #7
Factors related to the epigenetic profile in bronchiectasis
20250 citationsauthor #8
Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection.
20250 citationsauthor #4
Longitudinal trajectories of tobacco and alcohol use following first or consecutive admissions for respiratory diseases
20250 citationsauthor #8
CC16: a biomarker of disease severity and Pseudomonas infection in Bronchiectasis
20250 citationsauthor #7
Quality of life decline in Pseudomonas aeruginosa-colonized bronchiectasis: A longitudinal nursing perspective
20250 citationsauthor #9
Accelerated epigenetic age in Bronchiectasis
20250 citationsauthor #6
Healthcare worker views on antimicrobial resistance in chronic respiratory disease
20252 citationsauthor #193
Peripheral immune cells are associated with disease severity and chronic P. aeruginosa infection in Bronchiectasis
20240 citationsauthor #7
The profile of blood methylation is associated with disease severity in bronchiectasis
20240 citationsauthor #8
The value of biofilm testing to guide antimicrobial stewardship in chronic respiratory diseases
20231 citationsauthor #12
Association between the lung microbiome and severity scores in bronchiectasis
20230 citationsauthor #8
Sputum colour as an indicator of quality of life in patients with bronchiectasis
20231 citationsauthor #8
Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis
20224 citationsauthor #6
Future Directions in Bronchiectasis Research.
202212 citationsauthor #1
The Hidden Pseudomonas Pathobiome and its Clinical Implications
20220 citationsauthor #10
Assessment of health-related quality of life in patients with bronchiectasis colonized by Pseudomonas aeruginosa
20210 citationsauthor #9
Development and characterization of a new swine model of invasive pneumococcal pneumonia
20219 citationsauthor #1
Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year
20217 citationsauthor #6
Spectrum of Disease Manifestations in Patients with Selective Immunoglobulin E Deficiency
202117 citationsauthor #6
Pseudomonas aeruginosa in Bronchiectasis
202111 citationsauthor #3
The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis
20210 citationsauthor #7
Murine models of cardiovascular damage in lung diseases
20200 citationsauthor #7
Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study
20200 citationsauthor #7
Association between physical activity and risk of hospitalisation in bronchiectasis
202026 citationsauthor #7
Ceftaroline for Severe Community-Acquired Pneumonia: A Real-World Two-Center Experience in Italy and Spain: Ceftaroline for severe pneumonia.
20208 citationsauthor #6
Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia
20203 citationsauthor #11
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis
20200 citationsauthor #2
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa
202023 citationsauthor #8
Acute and Sustained IL-17a Response in Bronchiectasis Exacerbations as Marker of Chronic Inflammation
20200 citationsauthor #7
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.
20202 citationsauthor #9
Soluble P-selectin in Acute Exacerbations and Stable Bronchiectasis in Adults.
20195 citationsauthor #9
Longitudinal examination of bronchiectasis sputum allows the early Pseudomonas aeruginosa detection
20190 citationsauthor #8
Validation of an etiological diagnostic model in adults with a diagnosis of bronchiectasis
20190 citationsauthor #7
Recruitment manoeuvres dislodge mucus towards the distal airways in an experimental model of severe pneumonia
20199 citationsauthor #9
Platelet activation correlates with disease severity in bronchiectasis
20191 citationsauthor #8
Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study*
201919 citationsauthor #11
The role of systemic markers of inflammation in bronchiectasis
20191 citationsauthor #2
Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study
20195 citationsauthor #2
Patients with Stable and Acute Exacerbation of Bronchiectasis Present Increased Platelet Activation
20190 citationsauthor #8
An imported case of e-cigarette or vaping associated lung injury in Barcelona
201920 citationsauthor #2
The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis
20187 citationsauthor #1
Initial Inflammatory Profile in Community‐acquired Pneumonia Depends on Time since Onset of Symptoms
201847 citationsauthor #5
Invasive Disease vs Urinary Antigen‐Confirmed Pneumococcal Community‐Acquired Pneumonia
201718 citationsauthor #4
Previous Antibiotics Therapy is Associated with a Lower Incidence of Septic Shock and a Lower Need for Mechanical Ventilation in Patients with Community-Acquired Pneumonia.
20170 citationsauthor #1
Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.
20179 citationsauthor #1
Pneumococcal vaccination
201617 citationsauthor #2
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
201645 citationsauthor #1
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia
201620 citationsauthor #4
Characterization of pulmonary function and mechanics in a novel model of pneumococcal pneumonia
20151 citationsauthor #1
Bacteraemia in outpatients with community-acquired pneumonia
20158 citationsauthor #4
Development and characterization of a novel model of invasive pneumococcal pneumonia in invasively ventilated PIGS
20150 citationsauthor #2
Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia
20140 citationsauthor #8
Severity and outcomes of community acquired pneumonia in asthmatic patients.
201420 citationsauthor #4
Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome
201469 citationsauthor #5
Invasive mechanical ventilation in community acquired pneumonia
20140 citationsauthor #5
Late-breaking abstract: Smoking is associated with higher incidence of parapneumonic effusion in community-acquired pneumonia
20143 citationsauthor #1
Microbial aetiology and outcomes of CAP in bronchiectatic patients
20132 citationsauthor #4
Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia.
201358 citationsauthor #5
Invasive Pneumococcal Disease Today: Epidemiology, Treatment, and Prevention
20125 citationsauthor #3
Influence Of Long-Term Use Of Inhaled Corticoids On The Development Of Pleural Effusion In Community Acquired Pneumonia
20121 citationsauthor #6
Does health care associated pneumonia really exist?
20129 citationsauthor #2
Long-term use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia
20120 citationsauthor #6
Antibiotics Before Hospitalization for CAP: How They Influence the Outcome
20120 citationsauthor #1
¿Es asma, son bronquiectasias, o es un déficit de alfa-1-antitripsina?
20111 citationsauthor #1
Is it asthma, is it bronchiectasis…or is it an alpha-1-antitrypsin deficiency?
20110 citationsauthor #1
The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
201119 citationsauthor #3
Impact of guidelines on HAP and VAP outcomes
20110 citationsauthor #3
Is it Asthma, is it Bronchiectasis…or is it an Alpha-1-Antitrypsin Deficiency?☆
20111 citationsauthor #1
European Respiratory & Pulmonary Diseases
year unknown1 citationsauthor #37

TIMELINE

2011 21 citations

2012 15 citations

2013 60 citations

2014 92 citations

2015 9 citations

2016 82 citations

2017 27 citations

2018 54 citations

2019 60 citations

2020 62 citations

2021 44 citations

2022 16 citations

2023 2 citations

2024 0 citations

2025 2 citations

Unknown 1 citations

COAUTHOR MAP

CONCEPT FOOTPRINT